Complications and outcomes of trimethoprim–sulphamethoxazole as chemoprophylaxis for pneumocystis pneumonia in renal transplant recipients
- 6 January 2014
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 19 (3) , 157-163
Abstract
Background: Following a pneumocystis pneumonia (PCP) outbreak in our nephrology unit, all transplant patients were offered chemoprophylaxis with trimethoprim–sulphamethoxazole (TMP‐SMX) as the first line agent. A high rate of complications was noted. We aimed to quantify TMP‐SMX associated adverse events and evaluate its prophylactic benefit in their light. Potential risk factors for complications' development were also investigated.Method: This was an observational study of outcomes in transplant recipients commenced on TMP‐SMX prophylaxis for 1year period. End‐points were adverse events due to TMP‐SMX, the additional medical burden resulting from these events, and PCP diagnosis.Results: 290 patients commenced on TMP‐SMX. 110 (38%) developed complications with most common being rise in serum creatinine (Cr) (n = 63, 22%) followed by gastrointestinal symptoms (n = 15, 5%), and leucopenia (n = 5, 2%). PCP incidence fell from 19 cases in 19 months to 2 cases in 12 months. Baseline renal function (P = 0.019) was an independent predictors for developing rise in Cr with TMP‐SMX.Conclusion: Use of chemoprophylaxis is an effective strategy in dealing with a PCP outbreak but can lead to a high number of complications. Rises in serum Cr can cause significant concern and increase in the number of investigations.Keywords
This publication has 25 references indexed in Scilit:
- Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patientsBMC Medical Genomics, 2012
- Influence ofNAT2Polymorphisms on Sulfamethoxazole Pharmacokinetics in Renal Transplant RecipientsAntimicrobial Agents and Chemotherapy, 2012
- Renal Association Clinical Practice Guideline on Post-operative Care of the Kidney Transplant RecipientNephron Clinical Practice, 2011
- Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisalBone Marrow Transplantation, 2010
- Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant RecipientsAmerican Journal of Transplantation, 2009
- Complications Related to Dapsone Use for Pneumocystis Jirovecii Pneumonia Prophylaxis in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2005
- Trimethoprim-sulphamethoxazole does not affect the pharmacokinetics of sirolimus in renal transplant recipientsBritish Journal of Clinical Pharmacology, 2005
- Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: A two-case report and reviewLiver Transplantation and Surgery, 1997
- Effectiveness of low-dose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantationTransplant International, 1992
- Antimicrobial Agents in Adult Patients With Renal Insufficiency: Initial Dosage and General RecommendationsMayo Clinic Proceedings, 1987